Jacobs Levy Equity Management’s Bellerophon Therapeutics BLPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-2,119
Closed -$78K – 1273
2016
Q1
$78K Buy
+2,119
New +$78.6K ﹤0.01% 1050

Other funds holding BLPH

Jacobs Levy Equity Management's BLPH Position: Q2 2016 in Review

Jacobs Levy Equity Management sold out of Bellerophon Therapeutics (BLPH) in Q2 2016, closing a stake of 2,119 shares — an estimated $78K sold.

Jacobs Levy Equity Management first reported a position in BLPH in Q1 2016 and held it in 1 quarter. The position peaked at $78K in Q1 2016. 17 funds tracked by Wall St. Rank hold BLPH as of Q2 2016.

  • Jacobs Levy Equity Management reported no remaining Bellerophon Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 2,119 Bellerophon Therapeutics shares in Q2 2016, an estimated $78K.
  • Jacobs Levy Equity Management first reported a position in Bellerophon Therapeutics in Q1 2016 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Bellerophon Therapeutics position peaked at $78K in Q1 2016.
  • 17 funds tracked by Wall St. Rank held Bellerophon Therapeutics as of Q2 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.